研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2023 年的期刊文章 · 第 17 页
共 1511 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2023-05-10 到 2023-04-20。
按期刊、按主题看 →
Biometrika Other · 发表于 2023-05-10
P Alquier, M Gerber
摘要
Many modern datasets are collected automatically and are thus easily contaminated by outliers. This has led to a renewed interest in robust estimation, including new notions of robustness such as robustness to adversarial contamination of the data. However, most robust estimation methods are designed for a specific model. Notably, many methods were proposed recently to obtain robust estimators in linear models, or generalized linear models, and a few were developed for very specific settings, for example beta regression or sample selection models. In this paper we develop a new approach for robust estimation in arbitrary regression models, based on maximum mean discrepancy minimization. We build two estimators that are both proven to be robust to Huber-type contamination. For one of them, we obtain a non-asymptotic error bound and show that it is also robust to adversarial contamination, but this estimator is computationally more expensive to use in practice than the other one. As a by-product of our theoretical analysis of the proposed estimators, we derive new results on kernel conditional mean embedding of distributions that are of independent interest.
SiM Nonparametric & Semiparametric · 发表于 2023-05-10
Tong Wang, Wenlu Tang, Yuanyuan Lin, Wen Su
摘要
We consider the problem of estimating the nonparametric function in nonparametric logistic regression under semi‐supervised framework, where a relatively small size labeled data set collected by case‐control sampling and a relatively large size of unlabeled data containing only observations of predictors are available. This problem arises in various applications when the outcome variable is expensive or difficult to be observed directly. A two‐stage nonparametric semi‐supervised estimator based on spline method is proposed to estimate the target regression function by maximizing the likelihood function of the labeled case‐control data. The unlabeled data are used in the first stage for estimating the density function that involves in the likelihood function. The consistency and functional asymptotic normality of the semi‐supervised two‐stage estimator are established under mild conditions. The proposed method, by making use of the unlabeled data, produces more efficient estimation of the target function than the traditional supervised counterpart. The performance of the proposed method is evaluated through extensive simulation studies. An application is illustrated with an analysis of a skin segmentation data.
SiM Bayesian Methods · 发表于 2023-05-10
Glen McGee, Ander Wilson, Brent A. Coull, Thomas F. Webster
摘要
A key goal of environmental health research is to assess the risk posed by mixtures of pollutants. As epidemiologic studies of mixtures can be expensive to conduct, it behooves researchers to incorporate prior knowledge about mixtures into their analyses. This work extends the Bayesian multiple index model (BMIM), which assumes the exposure‐response function is a nonparametric function of a set of linear combinations of pollutants formed with a set of exposure‐specific weights. The framework is attractive because it combines the flexibility of response‐surface methods with the interpretability of linear index models. We propose three strategies to incorporate prior toxicological knowledge into construction of indices in a BMIM: (a) imposing directional homogeneity constraints on the weights, (b) structuring index weights by exposure transformations, and (c) placing informative priors on the index weights. We propose a novel prior specification that combines spike‐and‐slab variable selection with an informative Dirichlet distribution based on relative potency factors often derived from previous toxicological studies. In simulations we show that the proposed priors improve inferences when prior information is correct and can protect against misspecification suffered by naïve toxicological models when prior information is incorrect. Moreover, different strategies may be mixed‐and‐matched for different indices to suit available information (or lack thereof). We demonstrate the proposed methods on an analysis of data from the National Health and Nutrition Examination Survey and incorporate prior information on relative chemical potencies obtained from toxic equivalency factors available in the literature.
SMMR Meta-Analysis & Data Integration · 发表于 2023-05-10
Jiandong Shi, Dehui Luo, Xiang Wan, Yue Liu, Jiming Liu, Zhaoxiang Bian, Tiejun Tong
摘要
For clinical studies with continuous outcomes, when the data are potentially skewed, researchers may choose to report the whole or part of the five-number summary (the sample median, the first and third quartiles, and the minimum and maximum values) rather than the sample mean and standard deviation. In the recent literature, it is often suggested to transform the five-number summary back to the sample mean and standard deviation, which can be subsequently used in a meta-analysis. However, if a study contains skewed data, this transformation and hence the conclusions from the meta-analysis are unreliable. Therefore, we introduce a novel method for detecting the skewness of data using only the five-number summary and the sample size, and meanwhile, propose a new flow chart to handle the skewed studies in a different manner. We further show by simulations that our skewness tests are able to control the type I error rates and provide good statistical power, followed by a simulated meta-analysis and a real data example that illustrate the usefulness of our new method in meta-analysis and evidence-based medicine.
SiM High-Dimensional · 发表于 2023-05-10
Wei Xiong, Han Pan, Jianrong Wang, Maozai Tian
摘要
An innovated model‐free interaction screening procedure called the MCVIS is proposed for high dimensional data analysis. Specifically, we adopt the introduced MCV index for quantifying the importance of an interaction effect among predictors. Our proposed method is fully nonparametric and is capable of successfully selecting interactions even if the signal of parental main effects is weak. The MCVIS procedure has many distinctive features: (i) it can work with discrete, categorical and continuous covariates; (ii) it can deal with both categorical and continuous response, even handle the missing response; (iii) it is robust for heavy‐tailed distributions, thus well accommodates heterogeneity typically caused by high dimensionality; (iv) it enjoys the sure screening and ranking consistency properties, therefore achieves dimension reduction without information loss. In another respect, computational feasibility is a top concern in high dimensional data analysis, by transforming our MCV into several variants, the MCVIS procedure is simple and fast to implement. Extensive numerical experiments and comparisons confirm the effectiveness and wide applicability of our MCVIS procedure. We further illustrate the proposed methodology by empirical study of two real datasets. Supplementary materials are available online.
SiM Missing Data & Measurement Error · 发表于 2023-05-09
Lin Ge, Yuzi Zhang, Kevin C. Ward, Timothy L. Lash, Lance A. Waller, Robert H. Lyles
摘要
Summary: Surveillance research is of great importance for effective and efficient epidemiological monitoring of case counts and disease prevalence. Taking specific motivation from ongoing efforts to identify recurrent cases based on the Georgia Cancer Registry, we extend recently proposed “anchor stream” sampling design and estimation methodology. Our approach offers a more efficient and defensible alternative to traditional capture‐recapture (CRC) methods by leveraging a relatively small random sample of participants whose recurrence status is obtained through a principled application of medical records abstraction. This sample is combined with one or more existing signaling data streams, which may yield data based on arbitrarily non‐representative subsets of the full registry population. The key extension developed here accounts for the common problem of false positive or negative diagnostic signals from the existing data stream(s). In particular, we show that the design only requires documentation of positive signals in these non‐anchor surveillance streams, and permits valid estimation of the true case count based on an estimable positive predictive value (PPV) parameter. We borrow ideas from the multiple imputation paradigm to provide accompanying standard errors, and develop an adapted Bayesian credible interval approach that yields favorable frequentist coverage properties. We demonstrate the benefits of the proposed methods through simulation studies, and provide a data example targeting estimation of the breast cancer recurrence case count among Metro Atlanta area patients from the Georgia Cancer Registry‐based Cancer Recurrence Information and Surveillance Program (CRISP) database.
SiM Longitudinal Data · 发表于 2023-05-09
Nicholas Devogel, Paul L. Auer, Regina Manansala, Tao Wang
摘要
In this study, the asymptotic distributions of the likelihood ratio test (LRT), the restricted likelihood ratio test (RLRT), the F and the sequence kernel association test (SKAT) statistics for testing an additive effect of the expected familial relatedness (FR) in a linear mixed model are examined based on an eigenvalue approach. First, the covariance structure for modeling the FR effect in a LMM is presented. Then, the multiplicity of eigenvalues for the log‐likelihood and restricted log‐likelihood is established under a replicate family setting and extended to a more general replicate family setting (GRFS) as well. After that, the asymptotic null distributions of LRT, RLRT, F and SKAT statistics under GRFS are derived. The asymptotic null distribution of SKAT for testing genetic rare variants is also constructed. In addition, a simple formula for sample size calculation is provided based on the restricted maximum likelihood estimate of the effect size for the expected FR. Finally, a power comparison of these test statistics on hypothesis test of the expected FR effect is made via simulation. The four test statistics are also applied to a data set from the UK Biobank.
SiM Longitudinal Data Missing Data & Measurement Error Causal Inference · 发表于 2023-05-09
Yiwang Zhou, Peter X. K. Song
摘要
Longitudinal outcomes are prevalent in clinical studies, where the presence of missing data may make the statistical learning of individualized treatment rules (ITRs) a much more challenging task. We analyzed a longitudinal calcium supplementation trial in the ELEMENT Project and established a novel ITR to reduce the risk of adverse outcomes of lead exposure on child growth and development. Lead exposure, particularly in the form of in utero exposure, can seriously impair children's health, especially their cognitive and neurobehavioral development, which necessitates clinical interventions such as calcium supplementation intake during pregnancy. Using the longitudinal outcomes from a randomized clinical trial of calcium supplementation, we developed a new ITR for daily calcium intake during pregnancy to mitigate persistent lead exposure in children at age 3 years. To overcome the technical challenges posed by missing data, we illustrate a new learning approach, termed longitudinal self‐learning (LS‐learning), that utilizes longitudinal measurements of child's blood lead concentration in the derivation of ITR. Our LS‐learning method relies on a temporally weighted self‐learning paradigm to synergize serially correlated training data sources. The resulting ITR is the first of this kind in precision nutrition that will contribute to the reduction of expected blood lead concentration in children aged 0‐3 years should this ITR be implemented to the entire study population of pregnant women.
SiM Bayesian Methods Clinical Trials · 发表于 2023-05-09
Alessandra Serra, Pavel Mozgunov, Thomas Jaki
摘要
Multi‐Arm Multi‐Stage (MAMS) designs can notably improve efficiency in later stages of drug development, but they can be suboptimal when an order in the effects of the arms can be assumed. In this work, we propose a Bayesian multi‐arm multi‐stage trial design that selects all promising treatments with high probability and can efficiently incorporate information about the order in the treatment effects as well as incorporate prior knowledge on the treatments. A distinguishing feature of the proposed design is that it allows taking into account the uncertainty of the treatment effect order assumption and does not assume any parametric arm‐response model. The design can provide control of the family‐wise error rate under specific values of the control mean and we illustrate its operating characteristics in a study of symptomatic asthma. Via simulations, we compare the novel Bayesian design with frequentist multi‐arm multi‐stage designs and a frequentist order restricted design that does not account for the order uncertainty and demonstrate the gains in the sample sizes the proposed design can provide. We also find that the proposed design is robust to violations of the assumptions on the order.
Biometrika Causal Inference · 发表于 2023-05-08
Yongchang Su, Xinran Li
摘要
Summary: Evaluating the treatment effect has become an important topic for many applications. However, most existing literature focuses mainly on average treatment effects. When the individual effects are heavy tailed or have outlier values, not only may the average effect not be appropriate for summarizing treatment effects, but also the conventional inference for it can be sensitive and possibly invalid due to poor large-sample approximations. In this paper we focus on quantiles of individual treatment effects, which can be more robust in the presence of extreme individual effects. Moreover, our inference for them is purely randomization based, avoiding any distributional assumptions on the units. We first consider inference in stratified randomized experiments, extending the recent work by Caughey et al. (2021). We show that the computation of valid p-values for testing null hypotheses on quantiles of individual effects can be transformed into instances of the multiple-choice knapsack problem, which can be efficiently solved exactly or slightly conservatively. We then extend our approach to matched observational studies and propose a sensitivity analysis to investigate to what extent our inference on quantiles of individual effects is robust to unmeasured confounding. The proposed randomization inference and sensitivity analysis are simul- taneously valid for all quantiles of individual effects, noting that the analysis for the maximum or minimum individual effect coincides with the conventional analysis assuming constant treatment effects.
Biometrika Other · 发表于 2023-05-08
Timo Dimitriadis, Tobias Fissler, Johanna Ziegel
摘要
Summary: We characterize the full classes of M-estimators for semiparametric models of general functionals by formally connecting the theory of consistent loss functions from forecast evaluation with the theory of M-estimation. This novel characterization result allows us to leverage existing results on loss functions known from the literature on forecast evaluation in estimation theory. We exemplify advantageous implications for the fields of robust, efficient, equivariant and Pareto-optimal M-estimation.
Biometrika Clinical Trials Causal Inference · 发表于 2023-05-03
Zach Branson, Xinran Li, Peng Ding
摘要
Summary: Power analyses are an important aspect of experimental design, because they help determine how experiments are implemented in practice. It is common to specify a desired level of power and compute the sample size necessary to obtain that power. Such calculations are well known for completely randomized experiments, but there can be many benefits to using other experimental designs. For example, it has recently been established that rerandomization, where subjects are randomized until covariate balance is obtained, increases the precision of causal effect estimators. This work establishes the power of rerandomized treatment-control experiments, thereby allowing for sample size calculators. We find the surprising result that, while power is often greater under rerandomization than complete randomization, the opposite can occur for very small treatment effects. The reason is that inference under rerandomization can be relatively more conservative, in the sense that it can have a lower Type-I error at the same nominal significance level, and this additional conservativeness adversely affects power. This surprising result is due to treatment effect heterogeneity, a quantity often ignored in power analyses. We find that heterogeneity increases power for large effect sizes, but decreases power for small effect sizes.
Biometrics High-Dimensional · 发表于 2023-05-03
Kuangnan Fang, Jingmao Li, Qingzhao Zhang, Yaqing Xu, Shuangge Ma
摘要
Gene–environment (G–E) interactions have important implications for cancer outcomes and phenotypes beyond the main G and E effects. Compared to main-effect-only analysis, G–E interaction analysis more seriously suffers from a lack of information caused by higher dimensionality, weaker signals, and other factors. It is also uniquely challenged by the “main effects, interactions” variable selection hierarchy. Effort has been made to bring in additional information to assist cancer G–E interaction analysis. In this study, we take a strategy different from the existing literature and borrow information from pathological imaging data. Such data are a “byproduct” of biopsy, enjoys broad availability and low cost, and has been shown as informative for modeling prognosis and other cancer outcomes/phenotypes in recent studies. Building on penalization, we develop an assisted estimation and variable selection approach for G–E interaction analysis. The approach is intuitive, can be effectively realized, and has competitive performance in simulation. We further analyze The Cancer Genome Atlas (TCGA) data on lung adenocarcinoma (LUAD). The outcome of interest is overall survival, and for G variables, we analyze gene expressions. Assisted by pathological imaging data, our G–E interaction analysis leads to different findings with competitive prediction performance and stability.
JASA Spatial & Time Series Bayesian Methods High-Dimensional · 发表于 2023-05-02
Matthias Katzfuss, Florian Schäfer
摘要
A multivariate distribution can be described by a triangular transport map from the target distribution to a simple reference distribution.We propose Bayesian nonparametric inference on the transport map by modeling its components using Gaussian processes.This enables regularization and uncertainty quantification of the map estimation, while resulting in a closed-form and invertible posterior map.We then focus on inferring the distribution of a nonstationary spatial field from a small number of replicates.We develop specific transport-map priors that are highly flexible and are motivated by the behavior of a large class of stochastic processes.Our approach is scalable to high-dimensional distributions due to data-dependent sparsity and parallel computations.We also discuss extensions, including Dirichlet process mixtures for flexible marginals.We present numerical results to demonstrate the accuracy, scalability, and usefulness of our methods, including statistical emulation of non-Gaussian climate-model output. *(abstract via OpenAlex)*
SiM Testing & Uncertainty · 发表于 2023-05-02
Yanda Lang, Joseph W. McKean, Omer Ozturk
摘要
In this paper, we propose robust meta‐analysis procedures for individual studies that report a broad range of robust summary statistics for a two‐sample problem. Summary statistics of individual studies could be presented in different forms including full data, medians of the two samples, the Hodges‐Lehman and Wilcoxon estimates of the location shift parameters. Data synthesis is made under both fixed‐effect and random‐effect meta‐analysis models. We systematically compare these robust meta‐analysis procedures via simulation studies to meta‐analysis procedure based on sample means and variances from individual studies under a wide range of error distributions. We show that the coverage probabilities of the robust meta‐analysis confidence intervals are quite close to the nominal confidence level. We also show that mean square error (MSE) of the robust meta‐analysis estimator is considerably smaller than that of the non‐robust meta‐analysis estimator under the contaminated normal, heavy tailed and skewed error distributions. The robust meta‐analysis procedures are then applied to platelet count reduction for malaria infected patients in Ghana.
Biometrics Survival Analysis Causal Inference Missing Data & Measurement Error · 发表于 2023-05-02
Lingyun Lyu, Yu Cheng, Abdus S. Wahed
摘要
Q-learning has been one of the most commonly used methods for optimizing dynamic treatment regimes (DTRs) in multistage decision-making. Right-censored survival outcome poses a significant challenge to Q-Learning due to its reliance on parametric models for counterfactual estimation which are subject to misspecification and sensitive to missing covariates. In this paper, we propose an imputation-based Q-learning (IQ-learning) where flexible nonparametric or semiparametric models are employed to estimate optimal treatment rules for each stage and then weighted hot-deck multiple imputation (MI) and direct-draw MI are used to predict optimal potential survival times. Missing data are handled using inverse probability weighting and MI, and the nonrandom treatment assignment among the observed is accounted for using a propensity-score approach. We investigate the performance of IQ-learning via extensive simulations and show that it is more robust to model misspecification than existing Q-Learning methods, imputes only plausible potential survival times contrary to parametric models and provides more flexibility in terms of baseline hazard shape. Using IQ-learning, we developed an optimal DTR for leukemia treatment based on a randomized trial with observational follow-up that motivated this study.
SiM Longitudinal Data Clinical Trials Bayesian Methods · 发表于 2023-04-30
Lou E. Whitehead, Oliver Sailer, Miles D. Witham, James M. S. Wason
摘要
Basket trials are a novel clinical trial design in which a single intervention is investigated in multiple patient subgroups, or “baskets.” They offer the opportunity to share information between subgroups, potentially increasing power to detect treatment effects. Basket trials offer several advantages over running a series of separate trials, including reduced sample sizes, increased efficiency, and reduced costs. Primarily, basket trials have been undertaken in Phase II oncology settings, but could be a promising design in other areas where a shared underlying biological mechanism drives different diseases. One such area is chronic aging‐related diseases. However, trials in this area frequently have longitudinal outcomes, and therefore suitable methods are needed to share information in this setting. In this paper, we extend three Bayesian borrowing methods for a basket design with continuous longitudinal endpoints. We demonstrate our methods on a real‐world dataset and in a simulation study where the aim is to detect positive basketwise treatment effects. Methods are compared with standalone analysis of each basket without borrowing. Our results confirm that methods that share information can improve power to detect positive treatment effects and increase precision over independent analysis in many scenarios. In highly heterogeneous scenarios, there is a trade‐off between increased power and increased risk of type I errors. Our proposed methods for basket trials with continuous longitudinal outcomes aim to facilitate their applicability in the area of aging related diseases. Choice of method should be made based on trial priorities and the expected basketwise distribution of treatment effects.
SMMR Missing Data & Measurement Error Diagnostics & Prediction · 发表于 2023-04-27
Rose Sisk, Matthew Sperrin, Niels Peek, Maarten van Smeden, Glen Philip Martin
摘要
Background: In clinical prediction modelling, missing data can occur at any stage of the model pipeline; development, validation or deployment. Multiple imputation is often recommended yet challenging to apply at deployment; for example, the outcome cannot be in the imputation model, as recommended under multiple imputation. Regression imputation uses a fitted model to impute the predicted value of missing predictors from observed data, and could offer a pragmatic alternative at deployment. Moreover, the use of missing indicators has been proposed to handle informative missingness, but it is currently unknown how well this method performs in the context of clinical prediction models. Methods: We simulated data under various missing data mechanisms to compare the predictive performance of clinical prediction models developed using both imputation methods. We consider deployment scenarios where missing data is permitted or prohibited, imputation models that use or omit the outcome, and clinical prediction models that include or omit missing indicators. We assume that the missingness mechanism remains constant across the model pipeline. We also apply the proposed strategies to critical care data. Results: With complete data available at deployment, our findings were in line with existing recommendations; that the outcome should be used to impute development data when using multiple imputation and omitted under regression imputation. When missingness is allowed at deployment, omitting the outcome from the imputation model at the development was preferred. Missing indicators improved model performance in many cases but can be harmful under outcome-dependent missingness. Conclusion: We provide evidence that commonly taught principles of handling missing data via multiple imputation may not apply to clinical prediction models, particularly when data can be missing at deployment. We observed comparable predictive performance under multiple imputation and regression imputation. The performance of the missing data handling method must be evaluated on a study-by-study basis, and the most appropriate strategy for handling missing data at development should consider whether missing data are allowed at deployment. Some guidance is provided.
Biometrika Bayesian Methods Genetics & Omics Optimization & Learning Theory · 发表于 2023-04-26
Rajanala Samyak, Julia A Palacios
摘要
Summary: Rooted and ranked phylogenetic trees are mathematical objects that are useful in modelling hierarchical data and evolutionary relationships with applications to many fields such as evolutionary biology and genetic epidemiology. Bayesian phylogenetic inference usually explores the posterior distribution of trees via Markov chain Monte Carlo methods. However, assessing uncertainty and summarizing distributions remains challenging for these types of structures. While labelled phylogenetic trees have been extensively studied, relatively less literature exists for unlabelled trees that are increasingly useful, for example when one seeks to summarize samples of trees obtained with different methods, or from different samples and environments, and wishes to assess the stability and generalizability of these summaries. In our paper, we exploit recently proposed distance metrics of unlabelled ranked binary trees and unlabelled ranked genealogies, or trees equipped with branch lengths, to define the Fréchet mean, variance and interquartile sets as summaries of these tree distributions. We provide an efficient combinatorial optimization algorithm for computing the Fréchet mean of a sample or of distributions on unlabelled ranked tree shapes and unlabelled ranked genealogies. We show the applicability of our summary statistics for studying popular tree distributions and for comparing the SARS-CoV-2 evolutionary trees across different locations during the COVID-19 epidemic in 2020. Our current implementations are publicly available at https://github.com/RSamyak/fmatrix.
Biometrics Genetics & Omics · 发表于 2023-04-26
Mengyun Wu, Fan Wang, Yeheng Ge, Shuangge Ma, Yang Li
摘要
Genome-wide association studies (GWAS) have led to great successes in identifying genotype–phenotype associations for complex human diseases. In such studies, the high dimensionality of single nucleotide polymorphisms (SNPs) often makes analysis difficult. Functional analysis, which interprets SNPs densely distributed in a chromosomal region as a continuous process rather than discrete observations, has emerged as a promising avenue for overcoming the high dimensionality challenges. However, the majority of the existing functional studies continue to be individual SNP based and are unable to sufficiently account for the intricate underpinning structures of SNP data. SNPs are often found in groups (e.g., genes or pathways) and have a natural group structure. Additionally, these SNP groups can be highly correlated with coordinated biological functions and interact in a network. Motivated by these unique characteristics of SNP data, we develop a novel bi-level structured functional analysis method and investigate disease-associated genetic variants at the SNP level and SNP group level simultaneously. The penalization technique is adopted for bi-level selection and also to accommodate the group-level network structure. Both the estimation and selection consistency properties are rigorously established. The superiority of the proposed method over alternatives is shown through extensive simulation studies. A type 2 diabetes SNP data application yields some biologically intriguing results.
SMMR Survival Analysis Missing Data & Measurement Error · 发表于 2023-04-25
Varadan Sevilimedu, Lili Yu, Hani Samawi
摘要
The problem of misclassification in covariates is ubiquitous in survival data and often leads to biased estimates. The misclassification simulation extrapolation method is a popular method to correct this bias. However, its impact on Weibull accelerated failure time models has not been studied. In this paper, we study the bias caused by misclassification in one or more binary covariates in Weibull accelerated failure time models and explore the use of the misclassification simulation extrapolation in correcting for this bias, along with its asymptotic properties. Simulation studies are carried out to investigate the numerical properties of the resulting estimator for finite samples. The proposed method is then applied to colon cancer data obtained from the cancer registry at Memorial Sloan Kettering Cancer Center.
SiM Causal Inference Clinical Trials · 发表于 2023-04-25
Liang Li, Thomas Jemielita
摘要
The augmented randomized controlled trial (RCT) with hybrid control arm includes a randomized treatment group (RT), a smaller randomized control group (RC), and a large synthetic control (SC) group from real‐world data. This kind of trial is useful when there is logistics and ethics hurdle to conduct a fully powered RCT with equal allocation, or when it is necessary to increase the power of the RCT by incorporating real‐world data. A difficulty in the analysis of augmented RCT is that the SC and RC may be systematically different in the distribution of observed and unmeasured confounding factors, causing bias when the two control groups are analyzed together as hybrid controls. We propose to use propensity score (PS) analysis to balance the observed confounders between SC and RC. The possible bias caused by unmeasured confounders can be estimated and tested by analyzing propensity score adjusted outcomes from SC and RC. We also propose a partial bias correction (PBC) procedure to reduce bias from unmeasured confounding. Extensive simulation studies show that the proposed PS + PBC procedures can improve the efficiency and statistical power by effectively incorporating the SC into the RCT data analysis, while still control the estimation bias and Type I error inflation that might arise from unmeasured confounding. We illustrate the proposed statistical procedures with data from an augmented RCT in oncology.
SiM Clinical Trials Causal Inference Longitudinal Data · 发表于 2023-04-24
Eric R. Cohn, Tianchen Qian, Susan A. Murphy
摘要
Micro‐randomized trials (MRTs) are a novel experimental design for developing mobile health interventions. Participants are repeatedly randomized in an MRT, resulting in longitudinal data with time‐varying treatments. Causal excursion effects are the main quantities of interest in MRT primary and secondary analyses. We consider MRTs where the proximal outcome is binary and the randomization probability is constant or time‐varying but not data‐dependent. We develop a sample size formula for detecting a nonzero marginal excursion effect. We prove that the formula guarantees power under a set of working assumptions. We demonstrate via simulation that violations of certain working assumptions do not affect the power, and for those that do, we point out the direction in which the power changes. We then propose practical guidelines for using the sample size formula. As an illustration, the formula is used to size an MRT on interventions for excessive drinking. The sample size calculator is implemented in R package MRTSampleSizeBinary and an interactive R Shiny app. This work can be used in trial planning for a wide range of MRTs with binary proximal outcomes.
SiM Genetics & Omics · 发表于 2023-04-24
Pål V. Johnsen, Øyvind Bakke, Thea Bjørnland, Andrew Thomas DeWan, Mette Langaas
摘要
We investigate saddlepoint approximations of tail probabilities of the score test statistic in logistic regression for genome‐wide association studies. The inaccuracy in the normal approximation of the score test statistic increases with increasing imbalance in the response and with decreasing minor allele counts. Applying saddlepoint approximation methods greatly improve the accuracy, even far out in the tails of the distribution. By using exact results for a simple logistic regression model, as well as simulations for models with nuisance parameters, we compare double saddlepoint methods for computing two‐sided ‐values and mid‐‐values. These methods are also compared to a recent single saddlepoint procedure. We investigate the methods further on data from UK Biobank with skin and soft tissue infections as phenotype, using both common and rare variants.
SiM Longitudinal Data Missing Data & Measurement Error · 发表于 2023-04-24
Christos Thomadakis, Nikos Pantazis, Giota Touloumi
摘要
Likelihood‐based methods ignoring missingness at random (MAR) produce consistent estimates provided that the whole likelihood model is correct. However, the expected information matrix (EIM) depends on the missingness mechanism. It has been shown that calculating the EIM by considering the missing data pattern as fixed (naive EIM) is incorrect under MAR, but the observed information matrix (OIM) is valid under any MAR missingness mechanism. In longitudinal studies, linear mixed models (LMMs) are routinely applied, often without any reference to missingness. However, most popular statistical packages currently provide precision measures for the fixed effects by inverting only the corresponding submatrix of the OIM (naive OIM), which is effectively equivalent to the naive EIM. In this paper, we analytically derive the correct form of the EIM of LMMs under MAR dropout to compare its differences with the naive EIM, which clarifies why the naive EIM fails under MAR. The asymptotic coverage rate of the naive EIM is numerically calculated for two parameters (population slope and slope difference between two groups) under various dropout mechanisms. The naive EIM can severely underestimate the true variance, especially when the degree of MAR dropout is high. Similar trends emerge under misspecified covariance structure, where, even the full OIM may lead to incorrect inferences and sandwich/bootstrap estimators are generally required. Results from simulation studies and application to real data led to similar conclusions. In LMMs, the full OIM should be preferred to the naive EIM/OIM, though if misspecified covariance structure is suspected, robust estimators should be used.
SiM Clinical Trials · 发表于 2023-04-23
Kert Viele
摘要
Summary: Platform trials, with arms entering and leaving the trial over time, are complex. In addition to trial changes over time, certain arms in a platform may come with patient restrictions. Both of these issues (time and eligibility) can create biases in comparing active arms to control. The largest of these biases, using non‐concurrent controls or including control patients that were ineligible for an active arm, have been extensively discussed in the literature. Here we show that even restricting to concurrent, eligible controls can induce biases if proper allocation ratios are not maintained throughout the platform. We also build on results in Ventz et al. Biostat., 19:199–215, 2018 to describe an algorithm that guarantees comparability between active and control groups in arm analyses in both time and eligibility, and allows for both re‐randomization of patients and two‐stage randomization procedures. The resulting method is both flexible and easily implemented, allowing robust comparisons when assumptions that underlie alternative randomization methods are in doubt.
SiM Testing & Uncertainty · 发表于 2023-04-22
Angela Andreella, Jesse Hemerik, Livio Finos, Wouter Weeda, Jelle Goeman
摘要
Summary: We propose a permutation‐based method for testing a large collection of hypotheses simultaneously. Our method provides lower bounds for the number of true discoveries in any selected subset of hypotheses. These bounds are simultaneously valid with high confidence. The methodology is particularly useful in functional Magnetic Resonance Imaging cluster analysis, where it provides a confidence statement on the percentage of truly activated voxels within clusters of voxels, avoiding the well‐known spatial specificity paradox. We offer a user‐friendly tool to estimate the percentage of true discoveries for each cluster while controlling the family‐wise error rate for multiple testing and taking into account that the cluster was chosen in a data‐driven way. The method adapts to the spatial correlation structure that characterizes functional Magnetic Resonance Imaging data, gaining power over parametric approaches.
SiM Causal Inference Survival Analysis Longitudinal Data · 发表于 2023-04-22
Ruth H. Keogh, Jon Michael Gran, Shaun R. Seaman, Gwyneth Davies, Stijn Vansteelandt
摘要
Longitudinal observational data on patients can be used to investigate causal effects of time‐varying treatments on time‐to‐event outcomes. Several methods have been developed for estimating such effects by controlling for the time‐dependent confounding that typically occurs. The most commonly used is marginal structural models (MSM) estimated using inverse probability of treatment weights (IPTW) (MSM‐IPTW). An alternative, the sequential trials approach, is increasingly popular, and involves creating a sequence of “trials” from new time origins and comparing treatment initiators and non‐initiators. Individuals are censored when they deviate from their treatment assignment at the start of each “trial” (initiator or noninitiator), which is accounted for using inverse probability of censoring weights. The analysis uses data combined across trials. We show that the sequential trials approach can estimate the parameters of a particular MSM. The causal estimand that we focus on is the marginal risk difference between the sustained treatment strategies of “always treat” vs “never treat.” We compare how the sequential trials approach and MSM‐IPTW estimate this estimand, and discuss their assumptions and how data are used differently. The performance of the two approaches is compared in a simulation study. The sequential trials approach, which tends to involve less extreme weights than MSM‐IPTW, results in greater efficiency for estimating the marginal risk difference at most follow‐up times, but this can, in certain scenarios, be reversed at later time points and relies on modelling assumptions. We apply the methods to longitudinal observational data from the UK Cystic Fibrosis Registry to estimate the effect of dornase alfa on survival.
SiM Survival Analysis Nonparametric & Semiparametric · 发表于 2023-04-20
Vera H. Arntzen, Marta Fiocco, Nils Leitzinger, Ronald B. Geskus
摘要
Quarantine length for individuals who have been at risk for infection with SARS‐CoV‐2 has been based on estimates of the incubation time distribution. The time of infection is often not known exactly, yielding data with an interval censored time origin. We give a detailed account of the data structure, likelihood formulation and assumptions usually made in the literature: (i) the risk of infection is assumed constant on the exposure window and (ii) the incubation time follows a specific parametric distribution. The impact of these assumptions remains unclear, especially for the right tail of the distribution which informs quarantine policy. We quantified bias in percentiles by means of simulation studies that mimic reality as close as possible. If assumption (i) is not correct, then median and upper percentiles are affected similarly, whereas misspecification of the parametric approach (ii) mainly affects upper percentiles. The latter may yield considerable bias. We suggest a semiparametric method that provides more robust estimates without the need of a parametric choice. Additionally, we used a simulation study to evaluate a method that has been suggested if all infection times are left censored. It assumes that the width of the interval from infection to latest possible exposure follows a uniform distribution. This assumption gave biased results in the exponential phase of an outbreak. Our application to open source data suggests that focus should be on the level of information in the observations, as expressed by the width of exposure windows, rather than the number of observations.
SiM Testing & Uncertainty · 发表于 2023-04-20
Liang He, Ian Philipp, Stephanie Webster, Jacob v. B. Hjelmborg, Alexander M. Kulminski
摘要
A robust and fast two‐sample test for equal Pearson correlation coefficients (PCCs) is important in solving many biological problems, including, for example, analysis of differential co‐expression. However, few existing methods for this test can achieve robustness against deviation from normal distributions, accuracy under small sample sizes, and computational efficiency simultaneously. Here, we propose a new method for testing differential correlation using a saddlepoint approximation of the residual bootstrap (DICOSAR). To achieve robustness, accuracy, and efficiency, DICOSAR combines the ideas underlying the pooled residual bootstrap, the signed root of a likelihood ratio statistic, and a multivariate saddlepoint approximation. Through a comprehensive simulation study and a real data analysis of gene co‐expression, we demonstrate that DICOSAR is accurate and robust in controlling the type I error rate for detecting differential correlation and provides a faster alternative to the bootstrap and permutation methods. We further show that DICOSAR can also be used for testing differential correlation matrices. These results suggest that DICOSAR provides an analytical approach to facilitate rapid testing for the equality of PCCs in large‐scale analysis.
SMMR Survival Analysis Causal Inference · 发表于 2023-04-20
Linda Valeri, Cecile Proust-Lima, Weijia Fan, Jarvis T. Chen, Helene Jacqmin-Gadda
摘要
We propose a novel methodology to quantify the effect of stochastic interventions for a non-terminal intermediate time-to-event on a terminal time-to-event outcome. Investigating these effects is particularly important in health disparities research when we seek to quantify inequities in the timely delivery of treatment and its impact on patients’ survival time. Current approaches fail to account for time-to-event intermediates and semi-competing risks arising in this setting. Under the potential outcome framework, we define causal contrasts relevant in health disparities research and provide identifiability conditions when stochastic interventions on an intermediate non-terminal time-to-event are of interest. Causal contrasts are estimated in continuous time within a multistate modeling framework and analytic formulae for the estimators of the causal contrasts are developed. We show via simulations that ignoring censoring in intermediate and/or terminal time-to-event processes or ignoring semi-competing risks may give misleading results. This work demonstrates that a rigorous definition of the causal effects and joint estimation of the terminal outcome and intermediate non-terminal time-to-event distributions are crucial for valid investigation of interventions and mechanisms in continuous time. We employ this novel methodology to investigate the role of delaying treatment uptake in explaining racial disparities in cancer survival in a cohort study of colon cancer patients.
SMMR Bayesian Methods · 发表于 2023-04-20
Francesco Brizzi, Bernhard Steiert, Herbert Pang, Cheikh Diack, Mark Lomax, Robbie Peck, Zoe Morgan, Antoine Soubret
摘要
Bayesian historical borrowing has recently attracted growing interest due to the increasing availability of historical control data, as well as improved computational methodology and software. In this article, we argue that the statistical models used for borrowing may be suboptimal when they do not adjust for differing factors across historical studies such as covariates, dosing regimen, etc. We propose an alternative approach to address these shortcomings. We start by constructing a historical model based on subject-level historical data to accurately characterize the control treatment by adjusting for known between trials differences. This model is subsequently used to predict the control arm response in the current trial, enabling the derivation of a model-informed prior for the treatment effect parameter of another (potentially simpler) model used to analyze the trial efficacy (i.e. the trial model). Our approach is applied to neovascular age-related macular degeneration trials, employing a cross-sectional regression trial model, and a longitudinal non-linear mixed-effects drug–disease–trial historical model. The latter model characterizes the relationship between clinical response, drug exposure and baseline covariates so that the derived model-informed prior seamlessly adapts to the trial population and can be extrapolated to a different dosing regimen. This approach can yield a more accurate prior for borrowing, thus optimizing gains in efficiency (e.g. increasing power or reducing the sample size) in future trials.